https://www.selleckchem.com/pr....oducts/atezolizumab.
Early-term newborns had a statistically significant increased risk of jaundice requiring treatment compared to term newborns (risk ratio= 1.91; 95%confidence interval [1.23-2.96]; p= .0046). Results of the repeated-measures analysis of variance and post hoc adjusted multiple comparison analysis showed that TcB levels increased to and peaked at 96 hours after birth and then gradually decreased to baseline (first measurement) levels at 30days after birth in each group. Early-term newborns should not be treated as full-term newborns b
Like
Comment
Share
